Predicted protein targets (top 13)
| gene | UniProt | supporting neighbours | confidence | |
|---|---|---|---|---|
| ▸ | FOLH1 | Q04609 | 9/20 | 0.55 |
| ▸ | ECE1 | P42892 | 1/20 | 0.46 |
| ▸ | GRIN2D | O15399 | 1/20 | 0.46 |
| ▸ | GRIN3B | O60391 | 1/20 | 0.46 |
| ▸ | GRIN1 | Q05586 | 1/20 | 0.46 |
| ▸ | GRIN2A | Q12879 | 1/20 | 0.46 |
| ▸ | GRIN2B | Q13224 | 1/20 | 0.46 |
| ▸ | GRIN2C | Q14957 | 1/20 | 0.46 |
| ▸ | GRIN3A | Q8TCU5 | 1/20 | 0.46 |
| ▸ | BACE1 | P56817 | 7/20 | 0.45 |
| ▸ | CTSD | P07339 | 2/20 | 0.44 |
| ▸ | NAALAD2 | Q9Y3Q0 | 1/20 | 0.44 |
| ▸ | CTSC | P53634 | 1/20 | 0.42 |
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6516241 | 0.95 | FOLH1 (0.55) | FOLH1ECE1GRIN2DGRIN3BGRIN1 | |
| SCHEMBL29485627 | 0.93 | FOLH1 (0.48) | FOLH1ECE1GRIN2DGRIN3BGRIN1 | |
| SCHEMBL30546210 | 0.93 | FOLH1 (0.55) | FOLH1GRIN2DGRIN3BGRIN1GRIN2A | |
| SCHEMBL31073601 | 0.91 | GRIN2D (0.47) | FOLH1ECE1GRIN2DGRIN3BGRIN1 | |
| SCHEMBL30974392 | 0.91 | FOLH1 (0.50) | FOLH1ECE1NAALAD2 | |
| SCHEMBL29564468 | 0.90 | FOLH1 (0.50) | FOLH1GRIN2DGRIN3BGRIN1GRIN2A | |
| SCHEMBL29531331 | 0.88 | FOLH1 (0.61) | FOLH1NAALAD2CTSC | |
| SCHEMBL29419017 | 0.88 | FOLH1 (0.61) | FOLH1NAALAD2CTSC | |
| SCHEMBL30544309 | 0.87 | ECE1 (0.49) | FOLH1ECE1GRIN2DGRIN3BGRIN1 | |
| SCHEMBL29485672 | 0.86 | FOLH1 (0.48) | FOLH1GRIN2DGRIN3BGRIN1GRIN2A |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| US-11807899-B2 | Biochemical reaction methods and reagents comprising intrinsically disordered regions | Biocrucible Limited | 2023-11-07 | — | — | US | disclosed |
| US-20220145378-A1 | BIOCHEMICAL REACTION METHODS AND REAGENTS COMPRISING INTRINSICALLY DISORDERED REGIONS | Biocrucible Limited (GB) | 2022-05-12 | — | — | US | disclosed |